Iuri Marques1, Nicola Jane Gray2, Jo Tsoneva3, Peter Magirr4,5, Alison Blenkinsopp6. 1. Senior Research Fellow in Safe Use of Medicines, School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK. 2. Independent Pharmacist Researcher, Green Line Consulting Limited, Manchester, UK. 3. Pharmacy Development Manager, NHS Sheffield Clinical Commissioning Group, Sheffield, UK. 4. Quality and Strategy Lead for Medicines Management, NHS Sheffield Clinical Commissioning Group, Sheffield, UK. 5. Board Member, Wicker Pharmacy, Sheffield, UK. 6. Professor of the Practice of Pharmacy, School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.
Abstract
BACKGROUND: The NHS in the UK supports pharmacists' deployment into general practices. This article reports on the implementation and impact of the Primary Care Pharmacy Programme (PCPP). The programme is a care delivery model that was undertaken at scale across a city in which community pharmacists (CPs) were matched with general practices and performed clinical duties for one half-day per week. AIM: To investigate (a) challenges of integration of CPs in general practices, and (b) the perceived impact on care delivery and community pharmacy practice. DESIGN & SETTING: This mixed-methods study was conducted with CPs, community pharmacy employers (CPEs), scheme commissioners (SCs), and patients in Sheffield. METHOD: Semi-structured interviews (n = 22) took place with CPs (n = 12), CPEs (n = 2), SCs (n = 3), and patients (n = 5). A cross-sectional survey of PCPP pharmacists (n = 47, 66%) was also used. A descriptive analysis of patient feedback forms was undertaken and a database of pharmacist activities was created. RESULTS: Eighty-six of 88 practices deployed a pharmacist. Although community pharmacy contracting and backfill arrangements were sometimes complicated, timely deployment was achieved. Development of closer relationships appeared to facilitate extension of initially agreed roles, including transition from 'backroom' to patient-facing clinical work. CPs gained understanding of GP processes and patients' primary care pathway, allowing them to follow up work at the community pharmacy in a more timely way, positively impacting on patients' and healthcare professionals' perceived delivery of care. CONCLUSION: The PCPP scheme was the first of its kind to achieve almost universal uptake by GPs throughout a large city. The study findings reveal the potential for CP-GP joint-working in increasing perceived positive care delivery and reducing fragmented care, and can inform future implementation at scale and at practice level.
BACKGROUND: The NHS in the UK supports pharmacists' deployment into general practices. This article reports on the implementation and impact of the Primary Care Pharmacy Programme (PCPP). The programme is a care delivery model that was undertaken at scale across a city in which community pharmacists (CPs) were matched with general practices and performed clinical duties for one half-day per week. AIM: To investigate (a) challenges of integration of CPs in general practices, and (b) the perceived impact on care delivery and community pharmacy practice. DESIGN & SETTING: This mixed-methods study was conducted with CPs, community pharmacy employers (CPEs), scheme commissioners (SCs), and patients in Sheffield. METHOD: Semi-structured interviews (n = 22) took place with CPs (n = 12), CPEs (n = 2), SCs (n = 3), and patients (n = 5). A cross-sectional survey of PCPP pharmacists (n = 47, 66%) was also used. A descriptive analysis of patient feedback forms was undertaken and a database of pharmacist activities was created. RESULTS: Eighty-six of 88 practices deployed a pharmacist. Although community pharmacy contracting and backfill arrangements were sometimes complicated, timely deployment was achieved. Development of closer relationships appeared to facilitate extension of initially agreed roles, including transition from 'backroom' to patient-facing clinical work. CPs gained understanding of GP processes and patients' primary care pathway, allowing them to follow up work at the community pharmacy in a more timely way, positively impacting on patients' and healthcare professionals' perceived delivery of care. CONCLUSION: The PCPP scheme was the first of its kind to achieve almost universal uptake by GPs throughout a large city. The study findings reveal the potential for CP-GP joint-working in increasing perceived positive care delivery and reducing fragmented care, and can inform future implementation at scale and at practice level.
Entities:
Keywords:
community pharmacy services; general practice; patient care; primary health care
Authors: L Dolovich; K Pottie; J Kaczorowski; B Farrell; Z Austin; C Rodriguez; K Gaebel; C Sellors Journal: Clin Pharmacol Ther Date: 2008-03-19 Impact factor: 6.875
Authors: Anthony J Avery; Sarah Rodgers; Judith A Cantrill; Sarah Armstrong; Kathrin Cresswell; Martin Eden; Rachel A Elliott; Rachel Howard; Denise Kendrick; Caroline J Morris; Robin J Prescott; Glen Swanwick; Matthew Franklin; Koen Putman; Matthew Boyd; Aziz Sheikh Journal: Lancet Date: 2012-02-21 Impact factor: 79.321
Authors: Anthony J Avery; Sarah Rodgers; Judith A Cantrill; Sarah Armstrong; Rachel Elliott; Rachel Howard; Denise Kendrick; Caroline J Morris; Scott A Murray; Robin J Prescott; Kathrin Cresswell; Aziz Sheikh Journal: Trials Date: 2009-05-01 Impact factor: 2.279